- Bayer (BAYZF) has offered 14.76B Norwegian kroner ($2.41B) to acquire partner Algeta (ALGZF), with the bid of 336 kroner a share representing a 27% premium to the latter's last closing price.
- Earlier this month, Bayer and Algeta received EU marketing approval for prostate-cancer treatment Xofigo. (PR)
Bayer bids $2.41B for prostate-cancer drug partner
Nov 26 2013, 02:13 ET
This was corrected on 11/26/2013 at 06:51 AM.